Lifecore Biomedical, Inc.
LFCR · NASDAQ
5/25/2025 | 5/26/2024 | 5/28/2023 | 5/29/2022 | |
|---|---|---|---|---|
| Revenue | $128,867 | $128,261 | $103,269 | $111,270 |
| % Growth | 0.5% | 24.2% | -7.2% | – |
| Cost of Goods Sold | $88,569 | $86,411 | $75,284 | $72,204 |
| Gross Profit | $40,298 | $41,850 | $27,985 | $39,066 |
| % Margin | 31.3% | 32.6% | 27.1% | 35.1% |
| R&D Expenses | $8,258 | $8,575 | $8,736 | $7,839 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $44,046 | $40,463 | $38,969 | $34,659 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $5,239 | $1,656 | $2,076 | $8,359 |
| Operating Expenses | $57,543 | $50,694 | $49,781 | $50,857 |
| Operating Income | -$17,245 | -$8,844 | -$21,796 | -$11,791 |
| % Margin | -13.4% | -6.9% | -21.1% | -10.6% |
| Other Income/Exp. Net | -$21,429 | $18,358 | -$42,132 | -$8,896 |
| Pre-Tax Income | -$38,674 | $9,514 | -$63,928 | -$20,687 |
| Tax Expense | $43 | $183 | $308 | -$5,211 |
| Net Income | -$38,717 | $12,013 | -$99,563 | -$116,715 |
| % Margin | -30% | 9.4% | -96.4% | -104.9% |
| EPS | -1.27 | 0.39 | -3.32 | -3.97 |
| % Growth | -425.6% | 111.7% | 16.4% | – |
| EPS Diluted | -1.27 | 0.33 | -3.32 | -3.97 |
| Weighted Avg Shares Out | 34,819 | 30,474 | 29,958 | 29,466 |
| Weighted Avg Shares Out Dil | 34,819 | 36,658 | 29,958 | 29,466 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $68 | $81 |
| Interest Expense | $21,835 | $18,090 | $17,649 | $15,551 |
| Depreciation & Amortization | $8,027 | $8,000 | $13,177 | $18,061 |
| EBITDA | -$8,812 | $35,604 | -$33,170 | $12,844 |
| % Margin | -6.8% | 27.8% | -32.1% | 11.5% |